nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.131	0.282	CbGbCtD
Maraviroc—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0885	0.19	CbGbCtD
Maraviroc—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0844	0.182	CbGbCtD
Maraviroc—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0752	0.162	CbGbCtD
Maraviroc—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0441	0.0949	CbGbCtD
Maraviroc—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0417	0.0897	CbGbCtD
Maraviroc—CCR5—respiratory system—chronic obstructive pulmonary disease	0.0211	0.415	CbGeAlD
Maraviroc—CCR5—connective tissue—chronic obstructive pulmonary disease	0.0186	0.365	CbGeAlD
Maraviroc—CCR5—lung—chronic obstructive pulmonary disease	0.0112	0.22	CbGeAlD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCR2—chronic obstructive pulmonary disease	0.00745	0.0605	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.00596	0.0484	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—STAT4—chronic obstructive pulmonary disease	0.00584	0.0474	CbGpPWpGaD
Maraviroc—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00578	0.0469	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00511	0.0414	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.00505	0.041	CbGpPWpGaD
Maraviroc—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00418	0.0339	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL17A—chronic obstructive pulmonary disease	0.00416	0.0337	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—CD8A—chronic obstructive pulmonary disease	0.00386	0.0314	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.00317	0.0257	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—NOS2—chronic obstructive pulmonary disease	0.003	0.0243	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00281	0.0228	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD8A—chronic obstructive pulmonary disease	0.00279	0.0227	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.00248	0.0201	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00237	0.0192	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL8—chronic obstructive pulmonary disease	0.00226	0.0183	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.0022	0.0178	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00212	0.0172	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL1B—chronic obstructive pulmonary disease	0.00205	0.0166	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00188	0.0153	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00162	0.0132	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00157	0.0128	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.00148	0.012	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00143	0.0116	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00138	0.0112	CbGpPWpGaD
Maraviroc—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00126	0.0102	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00118	0.00958	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00117	0.00952	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.00115	0.00934	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00109	0.00888	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00108	0.00874	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00105	0.00856	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.001	0.00815	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000996	0.00808	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000954	0.00774	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000923	0.00749	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000915	0.00743	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000912	0.0074	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000899	0.00729	CbGpPWpGaD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00088	0.00714	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000868	0.00704	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00085	0.00689	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00081	0.00657	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000803	0.00652	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000795	0.00645	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000763	0.00619	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000735	0.00597	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000724	0.00587	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000717	0.00582	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000711	0.00577	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000703	0.0057	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000665	0.0054	CbGpPWpGaD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00064	0.00519	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000599	0.00486	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00057	0.00462	CbGpPWpGaD
Maraviroc—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00057	0.00158	CcSEcCtD
Maraviroc—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000565	0.00157	CcSEcCtD
Maraviroc—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000565	0.00156	CcSEcCtD
Maraviroc—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000564	0.00156	CcSEcCtD
Maraviroc—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000563	0.00156	CcSEcCtD
Maraviroc—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000561	0.00155	CcSEcCtD
Maraviroc—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000561	0.00155	CcSEcCtD
Maraviroc—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000561	0.00155	CcSEcCtD
Maraviroc—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000561	0.00155	CcSEcCtD
Maraviroc—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00056	0.00155	CcSEcCtD
Maraviroc—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00154	CcSEcCtD
Maraviroc—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00154	CcSEcCtD
Maraviroc—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000554	0.00154	CcSEcCtD
Maraviroc—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000553	0.00153	CcSEcCtD
Maraviroc—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00152	CcSEcCtD
Maraviroc—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00152	CcSEcCtD
Maraviroc—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000547	0.00152	CcSEcCtD
Maraviroc—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00151	CcSEcCtD
Maraviroc—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00054	0.0015	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000539	0.00437	CbGpPWpGaD
Maraviroc—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000532	0.00147	CcSEcCtD
Maraviroc—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00147	CcSEcCtD
Maraviroc—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00147	CcSEcCtD
Maraviroc—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000527	0.00146	CcSEcCtD
Maraviroc—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00146	CcSEcCtD
Maraviroc—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00145	CcSEcCtD
Maraviroc—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00145	CcSEcCtD
Maraviroc—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000519	0.00144	CcSEcCtD
Maraviroc—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.00144	CcSEcCtD
Maraviroc—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000514	0.00142	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000513	0.00142	CcSEcCtD
Maraviroc—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000511	0.00142	CcSEcCtD
Maraviroc—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00051	0.00141	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000508	0.00412	CbGpPWpGaD
Maraviroc—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000506	0.0014	CcSEcCtD
Maraviroc—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00137	CcSEcCtD
Maraviroc—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000489	0.00135	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000486	0.00135	CcSEcCtD
Maraviroc—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00135	CcSEcCtD
Maraviroc—Cough—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00135	CcSEcCtD
Maraviroc—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000482	0.00133	CcSEcCtD
Maraviroc—Cough—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00132	CcSEcCtD
Maraviroc—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00131	CcSEcCtD
Maraviroc—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00131	CcSEcCtD
Maraviroc—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00131	CcSEcCtD
Maraviroc—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00131	CcSEcCtD
Maraviroc—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00131	CcSEcCtD
Maraviroc—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000472	0.00131	CcSEcCtD
Maraviroc—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000472	0.00131	CcSEcCtD
Maraviroc—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00131	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000471	0.0013	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.0013	CcSEcCtD
Maraviroc—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00047	0.00381	CbGpPWpGaD
Maraviroc—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.0013	CcSEcCtD
Maraviroc—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000469	0.0013	CcSEcCtD
Maraviroc—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000465	0.00129	CcSEcCtD
Maraviroc—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00128	CcSEcCtD
Maraviroc—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00128	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00128	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000461	0.00374	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000461	0.00128	CcSEcCtD
Maraviroc—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00127	CcSEcCtD
Maraviroc—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000455	0.00126	CcSEcCtD
Maraviroc—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000455	0.00126	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000454	0.00368	CbGpPWpGaD
Maraviroc—CCR5—Disease—HDAC2—chronic obstructive pulmonary disease	0.000454	0.00368	CbGpPWpGaD
Maraviroc—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00125	CcSEcCtD
Maraviroc—Infection—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00125	CcSEcCtD
Maraviroc—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00124	CcSEcCtD
Maraviroc—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00124	CcSEcCtD
Maraviroc—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000446	0.00124	CcSEcCtD
Maraviroc—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000446	0.00124	CcSEcCtD
Maraviroc—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000445	0.00123	CcSEcCtD
Maraviroc—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00123	CcSEcCtD
Maraviroc—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.00123	CcSEcCtD
Maraviroc—Infection—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00123	CcSEcCtD
Maraviroc—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.00122	CcSEcCtD
Maraviroc—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000442	0.00122	CcSEcCtD
Maraviroc—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00044	0.00122	CcSEcCtD
Maraviroc—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000437	0.00121	CcSEcCtD
Maraviroc—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.00121	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000434	0.00352	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000434	0.00352	CbGpPWpGaD
Maraviroc—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000433	0.0012	CcSEcCtD
Maraviroc—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00119	CcSEcCtD
Maraviroc—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00118	CcSEcCtD
Maraviroc—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000425	0.00118	CcSEcCtD
Maraviroc—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000423	0.00117	CcSEcCtD
Maraviroc—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00117	CcSEcCtD
Maraviroc—CCR5—Disease—KL—chronic obstructive pulmonary disease	0.000422	0.00342	CbGpPWpGaD
Maraviroc—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00117	CcSEcCtD
Maraviroc—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000419	0.00116	CcSEcCtD
Maraviroc—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00116	CcSEcCtD
Maraviroc—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000415	0.00115	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00115	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00115	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000412	0.00334	CbGpPWpGaD
Maraviroc—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.00114	CcSEcCtD
Maraviroc—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000411	0.00114	CcSEcCtD
Maraviroc—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00113	CcSEcCtD
Maraviroc—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000409	0.00113	CcSEcCtD
Maraviroc—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000407	0.00113	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000406	0.00112	CcSEcCtD
Maraviroc—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000403	0.00112	CcSEcCtD
Maraviroc—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00111	CcSEcCtD
Maraviroc—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.0011	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000397	0.00322	CbGpPWpGaD
Maraviroc—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000395	0.00109	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00109	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00109	CcSEcCtD
Maraviroc—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00109	CcSEcCtD
Maraviroc—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00109	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00108	CcSEcCtD
Maraviroc—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00108	CcSEcCtD
Maraviroc—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00108	CcSEcCtD
Maraviroc—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00108	CcSEcCtD
Maraviroc—Pain—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00108	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000389	0.00315	CbGpPWpGaD
Maraviroc—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00108	CcSEcCtD
Maraviroc—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000388	0.00107	CcSEcCtD
Maraviroc—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00107	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00107	CcSEcCtD
Maraviroc—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000384	0.00106	CcSEcCtD
Maraviroc—Pain—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00106	CcSEcCtD
Maraviroc—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000381	0.00105	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00038	0.00308	CbGpPWpGaD
Maraviroc—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.00105	CcSEcCtD
Maraviroc—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.00105	CcSEcCtD
Maraviroc—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.00105	CcSEcCtD
Maraviroc—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00105	CcSEcCtD
Maraviroc—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000377	0.00104	CcSEcCtD
Maraviroc—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000376	0.00104	CcSEcCtD
Maraviroc—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.00104	CcSEcCtD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000375	0.00304	CbGpPWpGaD
Maraviroc—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.00104	CcSEcCtD
Maraviroc—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00103	CcSEcCtD
Maraviroc—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000373	0.00103	CcSEcCtD
Maraviroc—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00103	CcSEcCtD
Maraviroc—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00103	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00103	CcSEcCtD
Maraviroc—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00103	CcSEcCtD
Maraviroc—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00102	CcSEcCtD
Maraviroc—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00102	CcSEcCtD
Maraviroc—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00101	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000361	0.00293	CbGpPWpGaD
Maraviroc—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.000996	CcSEcCtD
Maraviroc—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000359	0.000996	CcSEcCtD
Maraviroc—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.000996	CcSEcCtD
Maraviroc—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000359	0.000996	CcSEcCtD
Maraviroc—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000358	0.000992	CcSEcCtD
Maraviroc—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.000984	CcSEcCtD
Maraviroc—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.000983	CcSEcCtD
Maraviroc—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000355	0.000983	CcSEcCtD
Maraviroc—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.000978	CcSEcCtD
Maraviroc—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000352	0.000975	CcSEcCtD
Maraviroc—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000352	0.000975	CcSEcCtD
Maraviroc—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.000973	CcSEcCtD
Maraviroc—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000342	0.00277	CbGpPWpGaD
Maraviroc—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00094	CcSEcCtD
Maraviroc—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00094	CcSEcCtD
Maraviroc—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.000928	CcSEcCtD
Maraviroc—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000335	0.000928	CcSEcCtD
Maraviroc—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.000927	CcSEcCtD
Maraviroc—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000328	0.000909	CcSEcCtD
Maraviroc—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000326	0.000904	CcSEcCtD
Maraviroc—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.000904	CcSEcCtD
Maraviroc—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.000891	CcSEcCtD
Maraviroc—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000322	0.000891	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000321	0.00089	CcSEcCtD
Maraviroc—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00032	0.000885	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000318	0.00258	CbGpPWpGaD
Maraviroc—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000878	CcSEcCtD
Maraviroc—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000876	CcSEcCtD
Maraviroc—CCR5—Disease—ERBB3—chronic obstructive pulmonary disease	0.000316	0.00256	CbGpPWpGaD
Maraviroc—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000315	0.000873	CcSEcCtD
Maraviroc—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.000862	CcSEcCtD
Maraviroc—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000311	0.000862	CcSEcCtD
Maraviroc—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000855	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000308	0.0025	CbGpPWpGaD
Maraviroc—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.000853	CcSEcCtD
Maraviroc—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000305	0.000844	CcSEcCtD
Maraviroc—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.000841	CcSEcCtD
Maraviroc—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.000836	CcSEcCtD
Maraviroc—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000301	0.000833	CcSEcCtD
Maraviroc—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.000833	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000295	0.0024	CbGpPWpGaD
Maraviroc—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000295	0.000816	CcSEcCtD
Maraviroc—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000815	CcSEcCtD
Maraviroc—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.000814	CcSEcCtD
Maraviroc—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000289	0.000801	CcSEcCtD
Maraviroc—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.000801	CcSEcCtD
Maraviroc—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.000794	CcSEcCtD
Maraviroc—Rash—Formoterol—chronic obstructive pulmonary disease	0.000287	0.000794	CcSEcCtD
Maraviroc—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.000793	CcSEcCtD
Maraviroc—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000286	0.000793	CcSEcCtD
Maraviroc—Headache—Formoterol—chronic obstructive pulmonary disease	0.000285	0.000789	CcSEcCtD
Maraviroc—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.000789	CcSEcCtD
Maraviroc—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.000786	CcSEcCtD
Maraviroc—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000283	0.000784	CcSEcCtD
Maraviroc—Rash—Montelukast—chronic obstructive pulmonary disease	0.000281	0.000778	CcSEcCtD
Maraviroc—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000281	0.000777	CcSEcCtD
Maraviroc—Depression—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000775	CcSEcCtD
Maraviroc—Headache—Montelukast—chronic obstructive pulmonary disease	0.000279	0.000773	CcSEcCtD
Maraviroc—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000766	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000276	0.00224	CbGpPWpGaD
Maraviroc—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000762	CcSEcCtD
Maraviroc—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000762	CcSEcCtD
Maraviroc—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.000756	CcSEcCtD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000273	0.00221	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000272	0.00221	CbGpPWpGaD
Maraviroc—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00075	CcSEcCtD
Maraviroc—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.00075	CcSEcCtD
Maraviroc—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.000749	CcSEcCtD
Maraviroc—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.000748	CcSEcCtD
Maraviroc—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00027	0.000748	CcSEcCtD
Maraviroc—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.000745	CcSEcCtD
Maraviroc—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.000735	CcSEcCtD
Maraviroc—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000265	0.000733	CcSEcCtD
Maraviroc—CCR5—Disease—NOS2—chronic obstructive pulmonary disease	0.000264	0.00214	CbGpPWpGaD
Maraviroc—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.000724	CcSEcCtD
Maraviroc—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.000706	CcSEcCtD
Maraviroc—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.000703	CcSEcCtD
Maraviroc—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000694	CcSEcCtD
Maraviroc—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000686	CcSEcCtD
Maraviroc—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.000682	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000245	0.00199	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000243	0.00198	CbGpPWpGaD
Maraviroc—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000671	CcSEcCtD
Maraviroc—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000652	CcSEcCtD
Maraviroc—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000633	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000224	0.00182	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000223	0.00181	CbGpPWpGaD
Maraviroc—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000617	CcSEcCtD
Maraviroc—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000617	CcSEcCtD
Maraviroc—CCR5—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000222	0.0018	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000221	0.0018	CbGpPWpGaD
Maraviroc—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000613	CcSEcCtD
Maraviroc—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000611	CcSEcCtD
Maraviroc—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000607	CcSEcCtD
Maraviroc—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000607	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000213	0.00173	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS3—chronic obstructive pulmonary disease	0.000212	0.00172	CbGpPWpGaD
Maraviroc—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.000583	CcSEcCtD
Maraviroc—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000561	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000198	0.00161	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000197	0.0016	CbGpPWpGaD
Maraviroc—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000545	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000195	0.00158	CbGpPWpGaD
Maraviroc—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000534	CcSEcCtD
Maraviroc—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000526	CcSEcCtD
Maraviroc—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000517	CcSEcCtD
Maraviroc—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000515	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000514	CcSEcCtD
Maraviroc—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000511	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000503	CcSEcCtD
Maraviroc—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000496	CcSEcCtD
Maraviroc—Infection—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000492	CcSEcCtD
Maraviroc—Shock—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000488	CcSEcCtD
Maraviroc—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000486	CcSEcCtD
Maraviroc—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000481	CcSEcCtD
Maraviroc—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000473	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.00133	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000452	CcSEcCtD
Maraviroc—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000451	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000163	0.00132	CbGpPWpGaD
Maraviroc—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000448	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00131	CbGpPWpGaD
Maraviroc—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000445	CcSEcCtD
Maraviroc—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000431	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000155	0.00126	CbGpPWpGaD
Maraviroc—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00043	CcSEcCtD
Maraviroc—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00043	CcSEcCtD
Maraviroc—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000427	CcSEcCtD
Maraviroc—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000427	CcSEcCtD
Maraviroc—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000424	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000148	0.0012	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000405	CcSEcCtD
Maraviroc—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000405	CcSEcCtD
Maraviroc—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000392	CcSEcCtD
Maraviroc—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000392	CcSEcCtD
Maraviroc—CCR5—Disease—TGFB1—chronic obstructive pulmonary disease	0.00014	0.00114	CbGpPWpGaD
Maraviroc—CCR5—Disease—EGFR—chronic obstructive pulmonary disease	0.000137	0.00111	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000137	0.00111	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000135	0.00109	CbGpPWpGaD
Maraviroc—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000365	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000132	0.00107	CbGpPWpGaD
Maraviroc—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000356	CcSEcCtD
Maraviroc—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000351	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000125	0.00102	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000125	0.00102	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000124	0.001	CbGpPWpGaD
Maraviroc—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000339	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000119	0.000966	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.000965	CbGpPWpGaD
Maraviroc—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000328	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.000952	CbGpPWpGaD
Maraviroc—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000315	CcSEcCtD
Maraviroc—Rash—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000313	CcSEcCtD
Maraviroc—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000312	CcSEcCtD
Maraviroc—Headache—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000311	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000107	0.000867	CbGpPWpGaD
Maraviroc—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000294	CcSEcCtD
Maraviroc—CCR5—Disease—IL6—chronic obstructive pulmonary disease	0.000106	0.000856	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.81e-05	0.000796	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.62e-05	0.00078	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	9.57e-05	0.000776	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.08e-05	0.000655	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.39e-05	0.0006	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.34e-05	0.000514	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.17e-05	0.0005	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.73e-05	0.000465	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.37e-05	0.000273	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.33e-05	0.00027	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.04e-05	0.000246	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.8e-05	0.000227	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.33e-05	0.000189	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.3e-05	0.000187	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.15e-05	0.000174	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.03e-05	0.000165	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.38e-05	0.000112	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.000107	CbGpPWpGaD
